+

Brand Name

+

Immune Checkpoint Inhibitor Class

+

Conventional Dosing

+

Extended-Interval Dosing

+

Fixed Dose or Capped Weight Based Dose

+

Treatment Duration

+

Preferred Dosing Frequency with Other Agents

+

Administration

+

Vial availability

+

Dose Relationship to efficacy and toxicity

+

Half-Life (5 x T1/2)

+

Unique Pharmacokinetics or Pharmacodynamics